Recent Advances in the Management of Primary Sclerosing Cholangitis
Clinical Gastroenterology and Hepatology · 2023-07 · 21 (8) · 2065-2075
DOI: 10.1016/j.cgh.2023.04.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-07. Verfasst von David N Assis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, Connecticut. Electronic address: david.assis@yale.edu. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Cholangiocarcinoma, Cholestasis, Bile Duct Neoplasms. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences, Novo Nordisk.
Abstract (Originalsprache)
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by fibroinflammatory damage to the biliary tree, typically in the setting of inflammatory bowel disease, with an increased risk of liver failure and cholangiocarcinoma. A complex pathophysiology, heterogeneity in clinical features, and the rare nature of the disease have contributed to the lack of effective therapy to date. However, recent innovations in the characterization and prognostication of patients with PSC, in addition to new tools for medical management and emerging pharmacologic agents, give rise to the potential for meaningful progress in the next several years. This review summarizes current concepts in PSC and highlights particular areas in need of further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale School of Medicine, New Haven, Connecticut. Electronic address: david.assis@yale.edu.
- University of California Davis Health, Sacramento, California.
Förderung
- Gilead Sciences
- Novo Nordisk
Zitieren
APA
Assis, D. N., & Bowlus, C. L. (2023). Recent Advances in the Management of Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology, 21(8), 2065-2075. https://doi.org/10.1016/j.cgh.2023.04.004
Vancouver
Assis DN, Bowlus CL. Recent Advances in the Management of Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology. 2023;21(8):2065-2075. doi:10.1016/j.cgh.2023.04.004
BibTeX
@article{Assis2023,
author = {Assis, David N and Bowlus, Christopher L},
title = {Recent Advances in the Management of Primary Sclerosing Cholangitis},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {8},
pages = {2065--2075},
doi = {10.1016/j.cgh.2023.04.004}
}
EUVIMED